Arsenal Bio, one of the few cell therapy companies able to raise significant capital amid a prolonged downturn, has laid just ...

A meeting of health secretary Robert F. Kennedy Jr., and anti-vaccine campaigner David Geier with leaders of the country’s ...

U.K.-based drugmaker GSK said it planned to invest $30 billion in the U.S. over five years, an announcement timed to this ...

Filed by Rep. Pat Ryan (D-NY), the bill is aimed at breaking up companies like UnitedHealth Group, which has purchased large ...

A Wednesday Senate hearing aimed to answer questions about the exodus of top leaders from the CDC last month. Instead, it ...

In a climate of fear CDC scientists are withdrawing names from papers, and local and global health agencies are losing ...

CAMBRIDGE, Mass. — Biogen on Tuesday held a ceremonial groundbreaking of its 16-story headquarters in Kendall Square, ...

The outlook for some 3 million people with narcolepsy worldwide could soon improve as drugmakers are racing to win approval ...

Sara Carter, formerly of Fox News, argues her firsthand reporting experience qualifies her for a leading role combating drug ...

President Trump, who has said European countries need to pay more for medicines, is in the U.K. this week, as a spat over ...

Semler Scientific will pay DOJ nearly $30 million to settle health care fraud claims related to its peripheral artery disease ...

Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...